Key result
Metabolic syndrome increased the risk of developing paroxysmal atrial fibrillation and/or atrial flutter in patients without structural heart diseases.
Why the study?
Does metabolic syndrome increase the risk of paroxysmal atrial fibrillation and/or atrial flutter in hospitalized patients without structural heart disease?
Cohort (n=592)
No
Does metabolic syndrome increase the risk of paroxysmal atrial fibrillation and/or atrial flutter in hospitalized patients without structural heart disease?
Metabolic syndrome, particularly driven by obesity (BMI ≥25 kg/m2), is independently associated with a nearly 3-fold increased risk of paroxysmal atrial fibrillation or flutter in patients without structural heart disease.
Answers are grounded in this paper and cite their sources.
Metabolic syndrome may elevate paroxysmal AF risk; hypothesis-generating for targeted interventions, with prospective trials needed before practice change.
Background Because metabolic syndrome is associated with cardiovascular diseases, its association with the risk of paroxysmal atrial fibrillation (PAF) and/or atrial flutter (PAFL) was examined in the present study. Methods and Results A prospective analysis was performed in 592 consecutive hospitalized patients without obvious structural heart diseases. Sinus rhythm was confirmed by electrocardiography in all patients. PAF/PAFL occurred in 32 (5%) and metabolic syndrome was present in 127 (21%) of the patients enrolled. PAF/PAFL occurred in 12 (9%) of the patients with metabolic syndrome, but only 20 (4%) of patients without metabolic syndrome (p=0.02). Multivariate logistic regression analysis showed that metabolic syndrome was a significant risk factor for PAF/PAFL that was independent of left atrial diameter (>44 mm) or age (>70 years) (odds ratio (OR) 2.8, 95% confidence interval (CI) 1.3-6.2, p<0.01). Among the 5 components of the metabolic syndrome, body mass index ≥25 kg/m2 was the most strongly associated with PAF/PAFL (OR; 3.0, 95% CI 1.2-7.4, p=0.02). Conclusions Metabolic syndrome is highly associated with PAF/PAFL in patients without structural heart diseases and obesity may be an underlying mechanism for the higher prevalence. (Circ J 2007; 71: 252 - 255)
No takes yet. Share an insight, caveat, or question.
Umetani et al. (2007) conducted a cohort in Metabolic syndrome (n=592). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Incidence of paroxysmal atrial fibrillation (PAF) and/or atrial flutter (PAFL) (OR 2.8, 95% CI 1.3-6.2, p=<0.01). Metabolic syndrome increased the risk of developing paroxysmal atrial fibrillation and/or atrial flutter in patients without structural heart diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: